Pharmaceuticals

Small Molecule Drug Discovery Market Research: Growth Projections and Trends 2030

February 18, 2026February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the small molecule drug discovery market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Small Molecule Drug Discovery Market by the end of 2030?

The small molecule drug discovery market has experienced rapid expansion in recent years. This market is projected to grow from $67.94 billion in 2025 to $75.56 billion in 2026, at a compound annual growth rate (CAGR) of 11.2%. The expansion observed in prior periods can be attributed to several factors, including increasing R&D investments by pharmaceutical companies, the rising prevalence of chronic diseases, advancements in molecular biology techniques, a growing demand for cost-effective therapeutics, and the emergence of contract research organizations (CROs).

The small molecule drug discovery market is projected for substantial expansion in the coming years. It is anticipated to reach $117.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.6%. This projected growth is driven by factors such as the incorporation of AI and machine learning into drug discovery, the proliferation of precision medicine programs, enhanced partnerships between biotechnology and pharmaceutical companies, the implementation of automated high-throughput systems, and an intensifying focus on uncommon and intricate diseases. Key trends for this period encompass the widespread use of high-throughput screening, breakthroughs in combinatorial chemistry, the incorporation of nanotechnology into drug design, the evolution of personalized medicine, and improvements in target validation and lead optimization processes.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp

What Drivers Are Shaping Future Opportunities In The Small Molecule Drug Discovery Market?

The increasing prevalence of chronic diseases is anticipated to drive the expansion of the small molecule drug discovery market in the future. Chronic illnesses are defined as health conditions persisting for a year or more, interfering with daily activities, requiring ongoing medical attention, or a combination of these factors. Small-molecule drugs offer a treatment option for long-term ailments such as HIV, cancer, infections, heart disease, and renal disease, typically providing a more cost-effective solution for those affected by these conditions. Consequently, the growing occurrence of chronic diseases is projected to stimulate the small molecule drug discovery market. For example, a 2023 publication from the National Institutes of Health (NIH), a US-based biomedical research agency, estimates that by 2050, the number of individuals aged 50 and above in the United States with at least one chronic illness will reach 142.66 million. Furthermore, the number of people facing multimorbidity is forecasted to climb to 14.968 million by the same year. This rising incidence of chronic diseases is thus a key factor propelling the growth of the small molecule drug discovery market.

Which Segments Are Gaining Traction In The Small Molecule Drug Discovery Market?

The small molecule drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule Drugs, Biologic Drugs

2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others

3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others

4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization

5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others

Subsegments:

1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs

2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies

What Industry Trends Are Transforming The Small Molecule Drug Discovery Market?

Leading companies engaged in small molecule drug discovery are establishing partnerships to increase market revenues. Such collaborations frequently stimulate innovation by bringing together the specialized knowledge of diverse entities. For instance, in November 2023, Evommune, a US-based non-profit organization, and Accutar Biotechnology, a US-based biotechnology company, publicized a strategic partnership concentrating on AI-based drug discovery, specifically aimed at chronic inflammatory diseases. This joint endeavor intends to harness Accutar’s proprietary AI platform and Evommune’s expertise to identify novel small molecule drug candidates.

Who Are The Core Companies Influencing Trends In The Small Molecule Drug Discovery Market?

Major companies operating in the small molecule drug discovery market are Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Allarity Therapeutics, Cyteir Therapeutics, BigHat Biosciences

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

Which Regions Are Projected To Dominate The Small Molecule Drug Discovery Market In The Coming Years?

North America was the largest region in the small molecule drug discovery market in 2025. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Small Molecule Drug Discovery Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9834&type=smp

Browse Through More Reports Similar to the Global Small Molecule Drug Discovery Market 2026, By The Business Research Company

Small Molecule Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

Small Molecule Active Pharmaceutical Ingredient Market Report 2026

https://www.thebusinessresearchcompany.com/report/small-molecule-active-pharmaceutical-ingredient-global-market-report

Rna Targeting Small Molecule Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-targeting-small-molecule-drug-discovery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795